Intradermal Injections of Bleomycin to Model Skin Fibrosis.
Systemic sclerosis (scleroderma) is a fibrotic condition characterized by immunologic abnormalities, vascular injury, and increased accumulation of extracellular matrix proteins in the affected organs. Although the etiology of scleroderma has not yet been fully elucidated, a growing body of evidence suggests that extracellular matrix overproduction by activated fibroblasts results from a complex interaction among endothelial cells, immunocytes, and fibroblasts, involving a number of mediators such as cytokines, chemokines, growth factors, and their receptors. For a better understanding of the pathophysiology of scleroderma, animal models are important tools. They reproduce several histological as well as biochemical aspects resembling human scleroderma, and we can learn lots of new findings through animal studies. On the other hand, it must be emphasized that there are no animal models so far exhibiting all the aspects of human scleroderma, and studying animal models cannot answer all the problems of human scleroderma. This paper introduces current concepts of various animal models for scleroderma and discusses their advantages/disadvantages, contribution to our understanding of the pathogenesis, and therapeutic approach for human scleroderma.
['Yamamoto|Toshiyuki|T|']
D000818:Animals D001761:Bleomycin D004195:Disease Models, Animal D005355:Fibrosis D007271:Injections, Intradermal D051379:Mice D012595:Scleroderma, Systemic D012871:Skin Diseases
Bleomycin Scleroderma Animal model